List of Tables
Table 1. Global Antimicrobial Peptides Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Antimicrobial Peptides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Antimicrobial Peptides Sales by Region (2020-2025) & (Mg)
Table 5. Global Antimicrobial Peptides Sales Forecast by Region (2026-2031) & (Mg)
Table 6. Global Antimicrobial Peptides Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Antimicrobial Peptides Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Antimicrobial Peptides Sales Volume by Type (2020-2025) & (Mg)
Table 9. Global Antimicrobial Peptides Sales Volume by Type (2026-2031) & (Mg)
Table 10. Global Antimicrobial Peptides Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Antimicrobial Peptides Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Antimicrobial Peptides Sales Volume by Application (2020-2025) & (Mg)
Table 13. Global Antimicrobial Peptides Sales Volume by Application (2026-2031) & (Mg)
Table 14. Global Antimicrobial Peptides Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Antimicrobial Peptides Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Antimicrobial Peptides Sales by Manufacturer (2020-2025) & (Mg)
Table 17. Global Antimicrobial Peptides Sales Share by Manufacturer (2020-2025)
Table 18. Antimicrobial Peptides Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Antimicrobial Peptides Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Antimicrobial Peptides Price (2020-2025) & (US$/Mg)
Table 21. Ranking of Global Top Antimicrobial Peptides Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2024)
Table 24. Antimicrobial Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Antimicrobial Peptides Market
Table 26. Manufacturers Antimicrobial Peptides Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. AnaSpec Company Information
Table 29. AnaSpec Description and Business Overview
Table 30. AnaSpec Antimicrobial Peptides Product
Table 31. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 32. AnaSpec Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 33. AnaSpec Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 34. AnaSpec Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 35. AnaSpec Recent Developments
Table 36. AMP Biotech Company Information
Table 37. AMP Biotech Description and Business Overview
Table 38. AMP Biotech Antimicrobial Peptides Product
Table 39. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 40. AMP Biotech Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 41. AMP Biotech Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 42. AMP Biotech Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 43. AMP Biotech Recent Developments
Table 44. Phoenix Biotech Company Information
Table 45. Phoenix Biotech Description and Business Overview
Table 46. Phoenix Biotech Antimicrobial Peptides Product
Table 47. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 48. Phoenix Biotech Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 49. Phoenix Biotech Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 50. Phoenix Biotech Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 51. Phoenix Biotech Recent Developments
Table 52. Novabiotics Company Information
Table 53. Novabiotics Description and Business Overview
Table 54. Novabiotics Antimicrobial Peptides Product
Table 55. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 56. Novabiotics Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 57. Novabiotics Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 58. Novabiotics Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 59. Novabiotics Recent Developments
Table 60. Chinese Peptide Company Information
Table 61. Chinese Peptide Description and Business Overview
Table 62. Chinese Peptide Antimicrobial Peptides Product
Table 63. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 64. Chinese Peptide Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 65. Chinese Peptide Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 66. Chinese Peptide Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 67. Chinese Peptide Recent Developments
Table 68. Ontores Company Information
Table 69. Ontores Description and Business Overview
Table 70. Ontores Antimicrobial Peptides Product
Table 71. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 72. Ontores Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 73. Ontores Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 74. Ontores Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 75. Ontores Recent Developments
Table 76. GenScript Company Information
Table 77. GenScript Description and Business Overview
Table 78. GenScript Antimicrobial Peptides Product
Table 79. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 80. GenScript Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 81. GenScript Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 82. GenScript Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 83. GenScript Recent Developments
Table 84. Hycult Biotech Company Information
Table 85. Hycult Biotech Description and Business Overview
Table 86. Hycult Biotech Antimicrobial Peptides Product
Table 87. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 88. Hycult Biotech Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 89. Hycult Biotech Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 90. Hycult Biotech Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 91. Hycult Biotech Recent Developments
Table 92. Sunsmile Company Information
Table 93. Sunsmile Description and Business Overview
Table 94. Sunsmile Antimicrobial Peptides Product
Table 95. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 96. Sunsmile Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 97. Sunsmile Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 98. Sunsmile Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 99. Sunsmile Recent Developments
Table 100. Ruixing Biotechnology Company Information
Table 101. Ruixing Biotechnology Description and Business Overview
Table 102. Ruixing Biotechnology Antimicrobial Peptides Product
Table 103. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 104. Ruixing Biotechnology Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 105. Ruixing Biotechnology Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 106. Ruixing Biotechnology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 107. Ruixing Biotechnology Recent Developments
Table 108. Zhongnong Yingtai Biotechnology Company Information
Table 109. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 110. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 111. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 112. Zhongnong Yingtai Biotechnology Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 113. Zhongnong Yingtai Biotechnology Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 114. Zhongnong Yingtai Biotechnology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 115. Zhongnong Yingtai Biotechnology Recent Developments
Table 116. Glam Technology Company Information
Table 117. Glam Technology Description and Business Overview
Table 118. Glam Technology Antimicrobial Peptides Product
Table 119. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 120. Glam Technology Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 121. Glam Technology Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 122. Glam Technology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 123. Glam Technology Recent Developments
Table 124. ProteLight Pharmaceutical & Biotechnology Company Information
Table 125. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 126. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 127. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 128. ProteLight Pharmaceutical & Biotechnology Sales Proportion of Antimicrobial Peptides by Product in 2024
Table 129. ProteLight Pharmaceutical & Biotechnology Sales Proportion of Antimicrobial Peptides by Application in 2024
Table 130. ProteLight Pharmaceutical & Biotechnology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2024
Table 131. ProteLight Pharmaceutical & Biotechnology Recent Developments
Table 132. North America Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 133. North America Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 134. North America Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 135. North America Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 136. North America Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 137. North America Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 138. Asia-Pacific Antimicrobial Peptides Sales by Region (2020-2025) & (Mg)
Table 139. Asia-Pacific Antimicrobial Peptides Sales by Region (2026-2031) & (Mg)
Table 140. Asia-Pacific Antimicrobial Peptides Revenue by Region (2020-2025) & (US$ Million)
Table 141. Asia-Pacific Antimicrobial Peptides Revenue by Region (2026-2031) & (US$ Million)
Table 142. Asia-Pacific Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 143. Asia-Pacific Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 144. Europe Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 145. Europe Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 146. Europe Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 147. Europe Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 148. Europe Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 149. Europe Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 150. Latin America Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 151. Latin America Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 152. Latin America Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 153. Latin America Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 154. Latin America Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 155. Latin America Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 156. Middle East and Africa Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 157. Middle East and Africa Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 158. Middle East and Africa Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 159. Middle East and Africa Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 160. Middle East and Africa Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 161. Middle East and Africa Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 162. Antimicrobial Peptides Key Raw Materials, Industry Status and Trend
Table 163. Antimicrobial Peptides Key Raw Materials and Upstream Suppliers
Table 164. Antimicrobial Peptides Clients Status and Trend
Table 165. Antimicrobial Peptides Typical Clients
Table 166. Antimicrobial Peptides Distributors
Table 167. Antimicrobial Peptides Market Trends
Table 168. Antimicrobial Peptides Market Drivers
Table 169. Antimicrobial Peptides Market Challenges
Table 170. Antimicrobial Peptides Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Global Antimicrobial Peptides Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Antimicrobial Peptides Sales Market Share by Type in 2024 & 2031
Figure 4. Plant Antimicrobial Peptides Product Picture
Figure 5. Microbial Antimicrobial Peptides Product Picture
Figure 6. Animal Antimicrobial Peptides Product Picture
Figure 7. Global Antimicrobial Peptides Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Antimicrobial Peptides Sales Market Share by Application in 2024 & 2031
Figure 9. Pharmaceuticals
Figure 10. Feed Additives
Figure 11. Others
Figure 12. Antimicrobial Peptides Report Years Considered
Figure 13. Global Antimicrobial Peptides Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antimicrobial Peptides Market Size 2020-2031 (US$ Million)
Figure 15. Global Antimicrobial Peptides Sales 2020-2031 (Mg)
Figure 16. Global Antimicrobial Peptides Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Antimicrobial Peptides Revenue Market Share by Region (2020-2031)
Figure 18. Global Antimicrobial Peptides Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Antimicrobial Peptides Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Antimicrobial Peptides Average Selling Price (ASP) by Type (2020-2025) & (US$/Mg)
Figure 21. Global Antimicrobial Peptides Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Antimicrobial Peptides Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Antimicrobial Peptides Average Selling Price (ASP) by Application (2020-2025) & (US$/Mg)
Figure 24. Plant Antimicrobial Peptides of Antimicrobial Peptides Revenue Market Share by Application, 2024 VS 2031
Figure 25. Microbial Antimicrobial Peptides of Antimicrobial Peptides Revenue Market Share by Application, 2024 VS 2031
Figure 26. Animal Antimicrobial Peptides of Antimicrobial Peptides Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Antimicrobial Peptides Sales Share by Manufacturer in 2024
Figure 28. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Plant Antimicrobial Peptides Market Sales Proportion by Manufacturer in 2024
Figure 30. Microbial Antimicrobial Peptides Market Sales Proportion by Manufacturer in 2024
Figure 31. Animal Antimicrobial Peptides Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Antimicrobial Peptides Revenue 2020-2031 (US$ Million)
Figure 33. North America Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Figure 34. North America Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Antimicrobial Peptides Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Antimicrobial Peptides Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Antimicrobial Peptides Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 40. Europe Antimicrobial Peptides Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Antimicrobial Peptides Sales Market Share by Country (2020-2031)
Figure 42. Europe Antimicrobial Peptides Revenue Market Share by Country (2020-2031)
Figure 43. Europe Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Figure 44. Europe Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 45. Latin America Antimicrobial Peptides Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Antimicrobial Peptides Sales Market Share by Country (2020-2031)
Figure 47. Latin America Antimicrobial Peptides Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Figure 49. Latin America Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Antimicrobial Peptides Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Figure 55. Antimicrobial Peptides Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Antimicrobial Peptides Raw Materials by Region in 2024
Figure 57. Antimicrobial Peptides Distribution Channels
Figure 58. Global Antimicrobial Peptides Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Antimicrobial Peptides Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
